Insider buying last 90 days
No open-market insider purchases were filed for BG in the last 90 days.
From Form 4 filings, dated to when each was filed.
Bunge's week centered on strong third-quarter results, with adjusted EPS of $2.56 beating the $2.41 estimate and up from $2.27 a year earlier, as North American soybean and softseed processing margins outperformed and Viterra integration benefits took hold, partly offset by weaker tropical oils and grain merchandising. The company reaffirmed full-year guidance and continues progressing Viterra synergies. Separately, Bunge extended its trade receivables securitization program to December 2027 and announced a cash dividend of EUR 0.72 with an ex-date of 17 November 2026. Multiple commentaries this week described the stock as trading below fair value given its earnings strength.
Shares closed at $101.18, up 2.1% on the day, but remain below both the 50-day average of $108.80 and the 200-day average of $116.77, with the 50-day also below the 200-day. Over the past six months the stock has returned -19.8%, though it is up 6.8% over the past year. The GekkoIndex reads 62.9, placing BG in the Accumulation zone. Price sits 15.6% below Gekko Fair Value of $119.85.
The next earnings date falls on 3 February 2027, 85 days out, placing it beyond a typical 20-trading-day holding window. No insider, Congress or unusual options activity appears in the current windows. Seasonally, the next 20 trading days have averaged a -3.1% return over 5 years, rising in just 1 of those years, a pattern worth noting given the stock's typical 20-day move of 5.4%. Consensus among 5 analysts stands at 5 buy ratings, with a consensus target of $139.22.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Bunge scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
Below 50 and 200-day
Close $101.65 is below the 50-day ($107.23) and 200-day ($116.48) averages, and the 50-day is below the 200-day.
See the chart59.5, Neutral
Reading 59.5 is in the Neutral zone.
See the GekkoIndex12.6% below
Price is 12.6% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 80 days
Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.
See earnings−4.4% on average
From this point in the calendar, the next 20 trading days averaged −4.4% over 5 years, rising in 0 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Bunge closed at $101.65 on Nov 13, 2026, +5.6% over the past year, inside a 52-week range of $88.24 to $134.87.
Use the left and right arrow keys to read daily values.
Put BG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Bunge sources, moves, processes and sells agricultural products on a global scale. Its work centers on oilseeds such as soybeans, canola, rapeseed and sunflower seeds, along with grains like wheat and corn, which it turns into vegetable oils, protein meals and a range of milled goods including flours, corn meals, masa and specialty grains such as quinoa and millet.
The company organizes its work across four areas. One handles the buying, storing, shipping and processing of raw crops for buyers such as livestock feed makers, millers and biofuel producers. Another turns oils into cooking oils, margarines, shortenings and mayonnaise for food manufacturers, restaurants and grocery retailers. A milling arm supplies flours, corn products and grain ingredients to food producers, while a separate division makes sugar and ethanol and generates electricity from sugarcane bagasse.
Bunge trades on the NYSE under the ticker BG.
Bunge’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 59.5, in the Neutral zone, down 6.7 points over five sessions.
Down 6.7 points over five sessions, from the Accumulation zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 55 | +0.8% | +3.8% | ||
| Accumulation | 225 | +0.8% | +2.0% | ||
| Neutral (current zone) | 391 | −0.4% | −0.5% | ||
| Distribution | 30 | +1.1% | +2.4% | ||
| Selling | 1 | Too few readings yet | |||
Average BG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Bunge trades 12.6% below Gekko Fair Value of $116.34, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Bunge shares are worth, recalculated every trading day.
$116.34
Gekko Fair Value, Nov 14, 2026
12.6% Undervalued
At the end of Aug 2026 the price was 7.3% below the estimate.
No open-market insider purchases were filed for Bunge, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for BG in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in BG were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Bunge has been buying back its own shares.
From company filings.
Bunge reports on Feb 3, 2027, before the open (80 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 3, 2027
Expected before the open, 80 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 29, 2026 | $2.56 est $2.41 | $23.80B est $23.28B | −4.1% |
| Jul 29, 2026 | $2.00 est $2.03 | $24.04B est $22.81B | −10.5% |
| Apr 29, 2026 | $1.83 est $1.77 | $21.86B est $23.38B | +0.6% |
| Feb 4, 2026 | $1.99 est $1.81 | $23.76B est $22.61B | −2.5% |
| Nov 5, 2025 | $2.27 est $1.97 | $22.16B est $14.73B | +0.9% |
| Jul 30, 2025 | $1.31 est $1.09 | $12.77B est $12.24B | +4.5% |
| May 7, 2025 | $1.81 est $1.28 | $11.64B est $13.02B | −2.4% |
| Feb 5, 2025 | $2.13 est $2.25 | $13.54B est $13.18B | −7.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Bunge is $139.22, +37.0% from the last close, from 5 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 5 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 30 | Barclays | $150 | +47.6% |
| Oct 30 | BMO Capital | $150 | +47.6% |
| Oct 27 | Morgan Stanley | $140 | +37.7% |
| Oct 14 | Barclays | $150 | +47.6% |
| Oct 12 | J.P. Morgan | $139 | +36.7% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Bunge averaged −4.4% across the last 5 years, rising in 0 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.5% | 3 of 5 |
| Next 10 trading days | +0.1% | 4 of 5 |
| Next 15 trading days | −3.7% | 0 of 5 |
| Next 20 trading days | −4.4% | 0 of 5 |
| Next 30 trading days | −4.8% | 1 of 5 |
For scale, BG’s typical 20-trading-day move in either direction is about 5.4%.
Bunge’s market cap is $19.53B, with a P/E ratio of 17.2 and revenue of $93.47B over the last twelve months.
Coverage of Bunge this week reads positive: 5 positive, 2 neutral and 0 negative headlines.
Bunge’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| ADMArcher-Daniels-Midland | Accumulation | 3.8% below |
| PPCPilgrim's Pride | Neutral | 37.7% below |
| CTVACorteva | Buying | 57.6% below |
| SEBSeaboard | Accumulation | 5.4% below |
| CALMCal-Maine Foods | Neutral | 28.0% below |
| AGROAdecoagro | Accumulation | 42.2% below |
A peer links to its own page where one exists.
Bunge’s market cap is $19.53B at the Nov 13, 2026 close of $101.65, with 192.1M shares outstanding. The shares trade on a P/E ratio of 17.2.
The consensus analyst 12-month price target for Bunge is $139.22, +37.0% from the last close. Of the 5 firms that rated the stock in the last 90 days, 5 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Bunge is undervalued: the Nov 13, 2026 close of $101.65 is 12.6% below Gekko Fair Value of $116.34. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Bunge is expected to report on Feb 3, 2027, before the market opens (80 days away). Analysts expect earnings of $3.16 per share on revenue of $24.54B. Bunge beat the earnings estimate in 6 of its last 8 reports, moving 4.1% on average across the report.
Bunge’s 52-week high is $134.87 and its 52-week low is $88.24; it closed at $101.65 on Nov 13, 2026, +5.6% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 1 as mixed (gekkoindex) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.